Record Business Insider: FIRM’s VACCINE BOOST
August 5, 2005
A NEW vaccine that could offer lifetime protection against all types of flu is being developed by UK biotech firm Acambis. Cambridge-based Acambis said the vaccine would end the need for people to have flu jabs each year and may also protect them againstany virulent new strains that emerge, such as bird flu. Shares in Acambis, who are best known for developing the smallpox vaccine ACAM2000, rose three per cent yesterday